Navigation Links
Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
Date:10/8/2007

SALT LAKE CITY, Utah - Mario R. Capecchi, Ph.D., distinguished professor of human genetics and biology at the University of Utahs Eccles Institute of Human Genetics and a Howard Hughes Medical Institute investigator, has won the 2007 Nobel Prize in Physiology or Medicine.

The announcement was made this morning by the Nobel Assembly at the Karolinska Institute, in Stockholm, Sweden. The prize recognizes Capecchis pioneering development of knockout mice technology, a gene-targeting technique that has revolutionized the study of mammalian biology and allowed the creation of animal models for hundreds of human diseases, including the modeling of cancers in the mouse.

Capecchi shared the Noble prize with Oliver Smithies, D.Phil., of the University of North Carolina, Chapel Hill, and Sir Martin Evans, Ph.D., at the University of Cardiff, Wales.

The Nobel committee cited the three for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells.

This is a tremendous honor for our University, for our Department of Human Genetics, and, specifically, for all the members of my laboratory, past and present who have contributed to this work, said Capecchi upon receiving notification of the Nobel Prize early this morning. The strong support and genuine interest of the University and Salt Lake City communities have been marvelous.

It is a great honor to share this prize with Drs. Oliver Smithies and Martin Evans. We have all been very fortunate in having a longstanding scientific friendship and in being able to profoundly contribute to each others work. This prize is a tribute to our collective efforts.

The Nobel tops a long list of prestigious honors for Capecchi, who, as a child, was forced to wander four years on the streets of Italy after the Nazis imprisoned his mother in a concentration camp. His achievements in gene targeting were recognized with
'/>"/>

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
2. Researchers pioneer new gene therapy technique using natural repair process
3. Diabetes researchers pioneer islet cell xenotransplantation in primate studies
4. Rice bioengineers pioneer techniques for knee repair
5. Nobelist discovers antidepressant protein in mouse brain
6. Comments, experts and background on the 2006 Nobel Prize in chemistry
7. Nobel Laureate finds elegant explanation for DNA transcribing enzymes high fidelity
8. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
9. LEGO-Like building blocks to halt cell growth wins Hebrew University prize
10. Australian wins prestigious prize in biodiversity informatics
11. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
(Date:11/23/2009)... CINCINNATINew research presents strong evidence t...e to both outdoor traffic-related pollution and in...s than one or the other exposure alone. , Envi...incinnati (UC) College of Medicine have shown that...elated particles and indoor endotoxin during early...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied ...ntain lily ( Hosta lancifolia ), a characteristic ...osely packed ripples along the edges. The simple c...n resulting from bending during differential growt..., stretching foam ribbons. , Haiyi Liang, a post...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3Immucor to Present at Upcoming Investor Conferences 56489 1FDA pharmaceutical import alert 56486 1
...g the approximately 23,000 genes found in human DN... as few as 50 to 100 that have no counterparts in ...he primate family known as hominoids, and there ma...distinctive contributions these genes likely make ...ey play. Now scientists at Washington University S...
...earchers have believed women choose partners based...ew study from The University of Texas at Austin re...r own attractiveness. , David Buss, psychology re...ings in Attractive Women Want it All: Good Genes, ...otional Commitment in this months Evolutionary Psy...
...08 On the evening of April 17th, in Philadelphia,...ting science and the spirit of discovery, nine ind...dals and two will be presented with prestigious Bo...a precursor to the Nobel Prize, are awarded for ou...tively impacted and enhanced the quality of human ...
Other Biology News:First study hints at insights to come from genes unique to humans 2First study hints at insights to come from genes unique to humans 3Do attractive women want it all? 2Science and technology take center stage this election year 2Science and technology take center stage this election year 3Science and technology take center stage this election year 4Science and technology take center stage this election year 5Science and technology take center stage this election year 6
(Date:11/25/2009)...v.25/PRNewswire/--Reportlinker.comannouncesthatane..., BrazilBioethanolMarketAnalysisandForecaststo2...razil-Bioethanol-Market-Analysis-and-Forecasts-to-...Forecaststo2013 ,, Summary ,, Thereportpro...anolmarketandtheBrazilbioethanolmarketinparticular...
(Date:11/24/2009)... The New York investment bank KTA Capital,s...greed an AU$6.7 mil convertible note private place...te placement was arranged by KTA Capital as Neuren... New York (PRWEB) November 23, 2...A Capital, LLC ("KTA Capital") has annou...
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)...v.24/PRNewswire/--BlueMarbleEnergyCorp.announcedto...ority(OPDA)wererecentlyawarded$2millionbyWashingto...inaprivate/publicpartnershiptoconstructthestate,sf...,WA. ,, "Thisinvestmentwillsignificantlyspeedth...stoLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgil...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...or 2008, SAN DIEGO, May 7 Volcano Corporation (N... of intravascular ultrasound,(IVUS), functional me...CT),products designed to enhance the diagnosis and...ease, today reported results for the first quarter... 2008, Volcano reported revenues of,$36.6 million,...
...onal Validation Data for Its MISSION(R) ... 7 Sigma-Aldrich(TM) (Nasdaq:,SIAL) and the secon...ed,functional validation of the Consortium,s colle...entiviral-based shRNA vector constructs.,Currently...unctional,validation process. Validated clones cov...
...g, Inc., the parent,company of VWR International, ...ill hold a conference call on Monday, May 19th to ...o: John M. Ballbach, Chairman, President and CE...esident & Chief Financial Officer, When:... Time (ET), How: Interested parties may partic...
Other Biology Technology:Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 2Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 3Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 4Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 5Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 6Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 7Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 8Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 9Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 10Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 11Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 12Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 13Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 2Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 3VWR Funding, Inc. to Hold First Quarter 2008 Financial Results Conference Call 2
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Anti-7H6 Antigen (tight-junction associated protein antigen) Monoclonal Antibody, Unconjugated, Clone 7H6 from Cell Sciences
Goat Anti-Ephrin B2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: